Genetic Engineering and Our Food: The GMO Revolution

01 From Selective Breeding to Recombinant DNA

Humans have been genetically modifying food for ten thousand years. Every crop we eat today — wheat, corn, rice, soybeans — is the product of millennia of selective breeding, the practice of saving seeds from plants with desirable traits and replanting them generation after generation. Teosinte, the wild grass from which modern corn descends, bears no resemblance to the large-eared, soft-kernelled plant that fills agricultural fields. The difference is the accumulated result of roughly 9,000 years of directed mutation and selection by indigenous farmers in Mesoamerica.

What changed in the 1970s was not the principle of genetic modification but its precision. Recombinant DNA technology, first demonstrated by Paul Berg in 1972 when he combined DNA from the SV40 monkey virus with lambda phage DNA, made it possible to cut a gene from one organism and paste it into another, across species barriers that selective breeding cannot cross. A bacterium could now carry a plant gene. A plant could express a bacterial protein. The genetic toolkit was no longer limited to mating organisms that could naturally reproduce with each other, and the era of transgenic agriculture began.

02 The First Generation: Bt and Roundup Ready

The first commercial genetically engineered crops were designed for pest resistance and herbicide tolerance. Bt corn and Bt cotton carry a gene from the bacterium Bacillus thuringiensis that produces a protein toxic to specific insect pests, particularly the European corn borer and the cotton bollworm. When the pest feeds on the engineered plant, the protein binds to receptors in the insect's gut and kills it, reducing or eliminating the need for external insecticide applications.

Roundup Ready crops, introduced by Monsanto in 1996, carry a bacterial gene that confers resistance to glyphosate, the broad-spectrum herbicide sold as Roundup. Farmers can spray an entire field with glyphosate, killing every weed in the canopy while leaving the engineered crop unharmed. The convenience was transformative: Roundup Ready soybeans, corn, cotton, and canola spread rapidly across the American Midwest and other agricultural regions, and by the mid-2010s, over 90 percent of U.S. soybean and cotton acreage was planted with genetically engineered varieties.

03 Golden Rice and the Nutrition Frontier

Not all genetically engineered crops serve industrial agriculture. Golden Rice was engineered in the late 1990s to produce beta-carotene, a precursor of vitamin A, in its endosperm. The intention was to address vitamin A deficiency, a condition that blinds and kills hundreds of thousands of children annually in regions where rice is the dietary staple. The genes for beta-carotene synthesis were transferred from daffodil and a soil bacterium into the rice genome, producing grains with a distinctive golden color.

Golden Rice became a lightning rod for the GMO debate. Proponents argued it represented a humanitarian application of genetic engineering that could save lives with minimal disruption to existing agricultural systems. Critics questioned its efficacy, noting that beta-carotene levels in early varieties were too low to meaningfully address deficiency, and raised concerns about corporate control of seed supply despite the developers' commitment to royalty-free distribution. After years of regulatory review, Golden Rice was approved for cultivation in the Philippines in 2021, though its commercial adoption remains limited and politically contested.

04 CRISPR and the Next Crop Generation

The arrival of CRISPR-Cas9 has opened a new chapter in agricultural genetic engineering. Unlike first-generation transgenic techniques, which insert foreign genes from other species, CRISPR can make precise edits to a plant's own genome — knocking out a gene, tweaking a regulatory sequence, or duplicating a beneficial allele — without introducing any foreign DNA. This distinction matters scientifically because it enables more predictable outcomes, and it matters regulatorily because some jurisdictions, including the United States and Japan, treat gene-edited crops differently from transgenic ones.

The crop pipeline now includes wheat resistant to powdery mildew, soybeans with altered oil profiles, tomatoes with extended shelf life, and rice varieties engineered for drought tolerance. The speed of development has increased dramatically: a CRISPR edit that once required years of backcrossing can now be designed and validated in months. The limitation is not the editing technology itself but the plant biology — understanding which genes to edit, how they interact, and how the edited traits perform across years of field trials in variable environments remains the slow and difficult work of crop science.

05 The Regulatory Divide

The global regulatory landscape for genetically engineered crops is deeply fractured. The United States, under a coordinated framework involving the USDA, EPA, and FDA, regulates engineered crops based on the trait rather than the process used to create it. A gene-edited plant with no foreign DNA may fall outside the regulatory definition of a regulated article entirely. Japan and Argentina have adopted similar process-light approaches for gene-edited crops.

The European Union has taken a different path. The EU's regulatory framework, rooted in a 2001 directive, treats any organism developed through genetic modification techniques as a GMO subject to extensive safety assessment, traceability, and labeling requirements, regardless of whether foreign DNA is present. A 2024 European Commission proposal would relax rules for certain gene-edited crops that could have been produced through conventional breeding, but as of 2026 this legislation remains under negotiation. The practical consequence is that gene-edited crops developed and approved in the Americas may be legally indistinguishable from conventional crops in one jurisdiction and treated as novel GMOs requiring years of safety review in another. This regulatory asymmetry creates a barrier to international trade in agricultural products and fragments the global research effort.

06 Herbicide Resistance and the Treadmill

The widespread adoption of herbicide-tolerant crops produced a secondary problem that the technology's designers did not fully anticipate: weed resistance. When glyphosate is applied across millions of hectares year after year, the selective pressure on weed populations is enormous. Any individual weed with a natural mutation that confers glyphosate resistance survives to reproduce, and within a few seasons, resistant populations can dominate a field. As of the mid-2020s, glyphosate-resistant weeds had been documented in over 50 species across dozens of countries, infesting an estimated 60 million hectares globally.

The response from agricultural chemical companies has been to engineer crops resistant to additional, older herbicides — dicamba and 2,4-D — effectively extending the herbicide tolerance model to a second generation of products. This treadmill, where each new resistance trait eventually selects for weeds that can defeat it, raises questions about the long-term sustainability of the chemical-intensive agricultural model that genetic engineering has accelerated. Integrated weed management, combining chemical, mechanical, and biological approaches, is increasingly advocated as an alternative, but adoption is slow where the convenience of a single spray application remains economically compelling.

07 The Safety Consensus and the Trust Gap

The scientific consensus on the safety of genetically engineered food currently on the market is robust. A comprehensive 2016 report by the U.S. National Academies of Sciences, Engineering, and Medicine reviewed roughly 900 studies and 20 years of data on engineered crops and found no evidence of adverse health effects from consuming foods derived from them. Similar conclusions have been reached by the World Health Organization, the European Food Safety Authority, and national academies in multiple countries. The engineered proteins present in commercialized crops have been assessed for allergenicity and toxicity, and no commercially approved GMO food has been linked to harm.

The gap between this scientific consensus and public perception remains wide. Survey data consistently shows that a substantial portion of consumers in Europe and North America report concerns about GMO safety, and GMO labeling requirements have been implemented or expanded in multiple jurisdictions in response to consumer demand. The trust gap is driven partly by a legacy of corporate opacity in the early years of the technology, partly by genuine uncertainty about long-term ecological effects of widespread transgene deployment, and partly by the broader cultural anxiety about industrial agriculture that GMOs have come to symbolize. Closing that gap will require transparency that the agricultural biotechnology industry has not historically practiced.